홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NUVL
#1011
Nuvalent, Inc. Class A Common Stock
105.020
0
USD
+1.28%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.28%
월간 변동
+6.37%
6달 변화
+10.61%
년간 변동율
+10.61%
이전 종가
103.690
0
Open
105.020
0
Bid
Ask
Low
105.020
0
High
105.020
0
양
86
마켓
주식
헬스케어
NUVL
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
42.88 M
51.27 M
58.63 M
66.16 M
73.18 M
—
Valuation ratios
Enterprise value
851.37 M
1.4 B
4.54 B
5.46 B
7.65 B
24.16 B
Price to earnings ratio
-8.94
-17.56
-35.07
-19.92
-17.19
-64.88
Price to sales ratio
-715.11
—
—
—
—
—
Price to cash flow ratio
-10.37
-22.15
-44.42
-28.09
-26.57
-95.09
Price to book ratio
1.46
3.11
6.32
4.86
5.86
9.93
EBITDA 비율에 대한 기업 가치
-58.27
—
—
—
—
—
Profitability ratios
Return on assets %
-0.16
-0.17
-0.17
-0.23
-0.3
-0.38
Return on equity %
-0.16
-0.18
-0.18
-0.24
-0.34
-0.43
Return on invested capital %
-4 077.26
-5 821.59
-6 691.14
-14.8 K
-4 505.8
-2 819.37
Gross margin %
100
—
—
—
—
—
Operating margin %
7 899.48
—
—
—
—
—
EBITDA margin %
7 962.41
—
—
—
—
—
Net margin %
7 989.31
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
33.07
24.54
22.83
20.96
15.27
54.06
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.84
-1.31
-1.71
-2.79
-3.79
-3.82
EBIT per share
-2.13
—
—
—
—
—
EBITDA per share
-2.12
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
13.23
9.51
12.36
16.84
18.87
60.93
Net current asset value per share
13.34
9.62
12.48
17.05
19.16
61.79
Tangible book value per share
13.08
9.32
12.03
16.11
17.17
56.09
Working capital per share
12.94
9.23
11.93
16.24
17.9
57.2
Book value per share
13.08
9.32
12.03
16.11
17.17
56.09
뉴스
Nuvation Bio 실적 발표 집중: 입트로지 모멘텀 시험대
Nuvation Bio earnings in focus: Ibtrozi momentum faces test
Does Nuvalent (NUVL) Have the Potential to Rally 37.26% as Wall Street Analysts Expect?
뉴밸런트, 4분기 손실 보고...폐암 치료제 FDA 결정 대기
Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug
Drugmakers turn to AI to speed trials, regulatory submissions
Nuvalent, 52주 신고가 경신…112.89 USD 기록
Nuvalent Inc stock hits 52-week high at 112.89 USD
FDA, 뉴발렌트의 ROS1 양성 NSCLC 치료제 NDA 접수
FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment
Nuvalent (NUVL) chief legal officer Miller sells $676k in stock
Nuvalent CSO Pelish sells shares worth $501,752